Skip to main content
Press Releases

Carevive Launches OPT-IN® – Building the Largest Real-World Cancer Patient Experience Database

By May 28, 2020June 30th, 2020No Comments
Carevive Launches OPT-IN™ - Building the Largest Real-World Cancer Patient Experience Database

A Novel Cancer Patient Experience Database

North Miami, Florida — May 28, 2020 — Carevive Systems, a leading oncology-focused health technology company, announced today that it has launched the Carevive Oncology Pragmatic Trials Investigator Network (Carevive OPT-IN®). This consortium of physician-researchers is collecting Patient Experience Data using Carevive’s digital platform in the following cancer types: lung cancer, breast cancer, ovarian cancer, and multiple myeloma.

Funded by a growing list of life science companies, Carevive OPT-IN® is a novel and unique real-world Patient Experience Database consisting of EHR-derived clinical data and longitudinal Patient-Reported Outcomes (PRO). Together, this combination presents the most comprehensive picture of real-world symptoms of disease and treatment in cancer.

Madelyn Trupkin Herzfeld, Founder & CEO of Carevive commented, “We are proud to have launched what will be the largest real-world Patient Experience Database in cancer. Our data will be used by clinicians to improve the lives of cancer patients through remote symptom monitoring and better patient engagement, while providing a first-in-class set of data to our life science partners that will accelerate cancer therapy development and delivery.”

Life science companies can license these data to:

  • Support drug development, commercial, and market access efforts with novel evidence and insights including how and when therapies are being used in the real-world setting, differences between trial results and real-world data as well as longitudinal patient experience
  • Conduct bespoke research in collaboration with Carevive OPT-IN® sites and their patients
  • Become Carevive design-partners in other cancer types

Over the next two years, Carevive will design and implement data collection for an additional 12 cancer types within an expanding set of Carevive OPT-IN® cancer centers.

“The ability to license these datasets today represents a critical advancement for life science companies who wish to incorporate Patient Experience data across their value chain” added Herzfeld. “Doing so will continue to inform them about the real-world cancer patient experience and positively impact patient care across the cancer landscape.”

About Carevive

Carevive Systems, founded in 2013, is an oncology-focused health technology company dedicated to understanding and improving the cancer patient experience. Our platform enables providers to deliver better quality cancer care, and patients to be more engaged in their treatment, which will improve survival outcomes. Use of Carevive in the clinic unlocks critical data on the real-world cancer patient experience to continuously improve patient care today and provide better access to novel therapies in the future. For more information, please visit or follow us @carevive.